BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30017564)

  • 21. [HIV-1 Rev and related inhibitors].
    Cao Y; Liu XY
    Yao Xue Xue Bao; 2007 Apr; 42(4):347-51. PubMed ID: 17633198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
    Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
    Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 Rev protein assembles on viral RNA one molecule at a time.
    Pond SJ; Ridgeway WK; Robertson R; Wang J; Millar DP
    Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1404-8. PubMed ID: 19164515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rev-RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates.
    Jackson PE; Tebit DM; Rekosh D; Hammarskjold ML
    AIDS Res Hum Retroviruses; 2016 Sep; 32(9):923-34. PubMed ID: 27147495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of HIV-1 replication by targeting the Rev protein.
    Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
    Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Structure of HIV-1 Rev Filaments Suggests a Bilateral Model for Rev-RRE Assembly.
    DiMattia MA; Watts NR; Cheng N; Huang R; Heymann JB; Grimes JM; Wingfield PT; Stuart DI; Steven AC
    Structure; 2016 Jul; 24(7):1068-80. PubMed ID: 27265851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains.
    Hoffmann D; Schwarck D; Banning C; Brenner M; Mariyanna L; Krepstakies M; Schindler M; Millar DP; Hauber J
    PLoS One; 2012; 7(6):e38305. PubMed ID: 22675540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Fluidity of the Human Immunodeficiency Virus Rev Response Element.
    Sherpa C; Grice SFJL
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31940828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-molecule studies reveal that DEAD box protein DDX1 promotes oligomerization of HIV-1 Rev on the Rev response element.
    Robertson-Anderson RM; Wang J; Edgcomb SP; Carmel AB; Williamson JR; Millar DP
    J Mol Biol; 2011 Jul; 410(5):959-71. PubMed ID: 21763499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA.
    Grewe B; Ehrhardt K; Hoffmann B; Blissenbach M; Brandt S; Uberla K
    PLoS One; 2012; 7(11):e48688. PubMed ID: 23133650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The arginine-rich RNA-binding motif of HIV-1 Rev is intrinsically disordered and folds upon RRE binding.
    Casu F; Duggan BM; Hennig M
    Biophys J; 2013 Aug; 105(4):1004-17. PubMed ID: 23972852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Mimicry Drives HIV-1 Rev-Mediated HERV-K Expression.
    O'Carroll IP; Fan L; Kroupa T; McShane EK; Theodore C; Yates EA; Kondrup B; Ding J; Martin TS; Rein A; Wang YX
    J Mol Biol; 2020 Dec; 432(24):166711. PubMed ID: 33197463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
    Pallesen J; Dong M; Besenbacher F; Kjems J
    FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function.
    Kula A; Guerra J; Knezevich A; Kleva D; Myers MP; Marcello A
    Retrovirology; 2011 Jul; 8():60. PubMed ID: 21771346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.
    Jackson PEH; Dzhivhuho G; Rekosh D; Hammarskjold ML
    Curr HIV Res; 2020; 18(2):85-98. PubMed ID: 31906839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.
    Prado S; Beltrán M; Coiras M; Bedoya LM; Alcamí J; Gallego J
    Biochem Pharmacol; 2016 May; 107():14-28. PubMed ID: 26896646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.